Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: A cohort study

Journal of Clinical Pharmacology

Volumn 50, Issue 5, 2010, Pages 598-605

  Wong, Martin C S ^a   Jiang, Johnny Y ^a   Griffiths, Sian M ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Adherence; Angiotensin converting enzyme inhibitors; Antihypertensive drugs; Associated factors; Ethnic Chinese

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH SERVICE; HONG KONG; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; SOCIAL STATUS;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIMARY HEALTH CARE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 77951200276     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009346058     Document Type: Article

References (38)

1. Kearney PM, Whelton M., Reynolds K., Muntner P., Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005 ; 365: 217-223. (Pubitemid 40138015)
2. He J., Whelton PK Elevated systolic blood pressure and risk of cardiovascular and renal disease: an overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J. 1999 ; 138: S211-219.
3. Kannel WB, Belanger AJ Epidemiology of heart failure. Am Heart J. 1991 ; 121: 951-957.
4. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990 ; 335: 765-774.
5. Wolf-Maier K., Cooper RS, Kramer H., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004 ; 43: 10-17.
6. Whelton PK, He J., Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa, and Asia. J Hum Hypertens. 2004 ; 18: 545-551.
7. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA. 1997 ; 277: 739-745.
8. Turnbull F. ; Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood-pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet. 2003 ; 362: 1527-1535.
9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991 ; 265: 3255-3264.
10. McMahon SW, Cutler JA, Furberg CD, Payne GH The effect of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized clinical trials. Prog Cardiovasc Dis. 1986 ; 29: 99-118.
11. Dahlof B., Lindholm LH, Hansson L., Schersten B., Ekbom T., Wester PO Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991 ; 338: 1281-1285.
12. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
13. HDFP Cooperative Group. Five-year findings of the hypertension detection and follow-up program: I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA. 1979 ; 242: 2562-2571.
14. Van Wijk BLG, Klungel OH, Heerdink ER, de Boer A. The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. J Hypertens. 2004 ; 22: 1831-1837.
15. Flack JM, Novikov SV, Ferrario CM Benefits of adherence to antihypertensive drug therapy. Eur Heart J. 1996 ; 17 (suppl A). 16-20.
16. Wong MCS, Jiang JY, Lam AT, Fung H., Griffiths S., Mercer SW Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens. 2008 ; 22: 714-716.
17. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC-7 report. JAMA. 2003 ; 289: 2560-2572.
18. Brown MJ Hypertension and ethnic group. BMJ. 2006 ; 332: 833-836.
19. van Wijk BLG, Shrank WH, Klungel OH, Schneeweiss S., Brookhart MA, Avorn J. A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens. 2008 ; 26: 145-153. (Pubitemid 350294860)
20. Wong MCS, Jiang JY, Tang JL, Lam A., Fung H., Mercer SW Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res. 2008 ; 8: 138.
21. HA and clinical research. Support, Output and Direction. http://www.ha.org.hk/ho/research-ethics/msdc-p181.pdf. Accessed October 06, 2009.
22. Wong MCS, Jiang JY, Griffiths S. Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study. J Epidemiol Community Health. 2009 ; (in Press).
23. Population by Census, 2006, Hong Kong Special Administrative Region, China. http://www.bycensus2006.gov.hk/data/data2/index.htm. Accessed March 16, 2009.
24. Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006 ; 47: 1039-1048.
25. Lee JY, Kusek JW, Greene PG, et al. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens. 1996 ; 9: 719-725.
26. Mallion JM, Baguet JP, Siche JP, Tremel F., de Gaudemaris R. Compliance, electronic monitoring and antihypertensive drugs. J Hypertens. 1998 ; 16 (suppl): S75 - S79.
27. Katz MH Multivariable Analysis: A Practical Guide for Clinicians. 2 nd ed. Cambridge, UK: Cambridge University Press ; 2006.
28. Inkster ME, Donnan PT, MacDonald TM, Sullivan FM, Fahey T. Adherence to antihypertensive medication and association with patient and practice factors. J Hum Hypertens. 2006; 20: 295-297.
29. Di Martino M., Veronesi C., Delgio Esposti L., et al. Adherence to antihypertensive drug treatment and blood pressure control: a real practice analysis in Italy. J Hum Hypertens. 2008; 22: 51-53.
30. Carter BL Adherence, quality of life, cost effectiveness, and the role of the pharmacist. In: Lip GYH, Hall JE, eds. Comprehensive Hypertension. Philadelphia: Mosby-Elsevier; 2007: 1119-1127.
31. Woo KS, Nicholls MG High prevalence of persistent cough with angiotensin-converting enzyme inhibitors in Chinese. Br J Clin Pharmacol. 1995 ; 40: 141-144.
32. Chan WK, Chan TY, Luk WK, Leung VK, Li TH, Critchley JA A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol. 1993 ; 44: 299-300.
33. Kaplan NM, Flynn JT Kaplans Clinical Hypertension. 9 th ed. Philadelphia: Lippincott Williams & Wilkins ; 2006.
34. Morisky DE, Green LW, Levine DM Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 ; 24: 67-74.
35. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 ; 37: 113-124.
36. Ogedegbe G., Mancuso CA, Allergrante JP, Charlson ME Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003 ; 56: 520-529.
37. Kim MT, Hill MN, Bone LR, Levine DM Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000 ; 15: 90-96.
38. Hunt JS, Siemienczuk J., Touchette D., Payne N. Impact of educational mailing on blood pressure of primary care patients with mild hypertension. J Gen Intern Med. 2004 ; 19: 925-930.